✉news HealthMedicine first seen 10 h ago, last 6 h ago, peak #25
Insilico Medicine Advances AI-Designed Drug for Autoimmune Diseases
Original: Insilico Medicine Nominates AI-Designed VAV1 Molecular Glue Degrader for Autoimmune Diseases
Insilico Medicine has nominated an AI-designed VAV1 molecular glue degrader as a preclinical drug candidate for the treatment of autoimmune diseases. The nomination marks another step in the company's strategy of using generative artificial intelligence to discover and design novel therapeutics, and the candidate will now move forward into further development.
Why now: It highlights growing momentum for AI-driven drug discovery in the pharmaceutical industry.
Rank over time, top of the chart is #1. 4 snapshots from 10 h ago to 6 h ago.
Evidence
- Insilico Medicine Nominates AI-Designed VAV1 Molecular Glue Degrader for Autoimmune Diseases · BioPharma APAC
API: https://socialmediatrends-api.osmike.com/v1/trends/2185075